27
Highlights From ATS 2013: An Update on Advances in COPD

Highlights From ATS 2013: An Update on Advances in COPD

Embed Size (px)

DESCRIPTION

Highlights From ATS 2013: An Update on Advances in COPD. Goals. Reports on the Long-Acting Muscarinic Antagonist Aclidinium. Beier et al Results. Beeh et al Report. Beeh et al Findings. Combination Inhaled Corticosteroid and LABA Therapy. Dransfield et al Findings. - PowerPoint PPT Presentation

Citation preview

Highlights From ATS 2013: An Update on Advances in COPD

Goals

Reports on the Long-Acting Muscarinic Antagonist Aclidinium

Beier et al Results

Beeh et al Report

Beeh et al Findings

Combination Inhaled Corticosteroid and LABA Therapy

Dransfield et al Findings

Abstracts From a Long-Term Safety Study of the Nebulized LABA Arformoterol

Donohue et al Findings

Donohue et al Findings (cont)

Make et al: Results of Evaluation of Lung Function

Hanania et al: Incidence of Adverse Events

Hanania et al Findings

Mahler et al Study

Mahler et al Findings

Retrospective Study Comparing Nebulized LABA With Nebulized SABA

Yeaw et al

Data on Emerging Therapies

Wedzicha et al Findingsa

Data on Emerging Therapies: Umeclidinium

Challenges and Conclusions

Challenges and Conclusions (cont)

Abbreviations

References

References (cont)

References (cont)